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Abstract

Background: There is a large disparity between the number of people waiting for organ
transplants and the number of organs available. Optimal hemodynamic management can
influence transplant outcomes, therefore evidence-based hemodynamic management should be
practiced to maximize scarce donor organs.
Purpose: The purpose of this study was to examine intraoperative blood pressures and
administration of volatile anesthetics during brain dead organ donor procurements. Use of
volatile anesthetics was examined to determine how use and dose affected the ability to maintain
mean arterial pressure (MAP) between 60 to 90 mmHg.
Design: This study was a retrospective chart review.
Results: Twenty-eight cases were analyzed using the mean MAP calculated for each donor.
Mean scores ranged from 61.04 to 99.34 mmHg with a mean of M= 84.51 mmHg. Twenty-two
donors (78.6%) received volatile anesthetic gas, and six donors (21.4%) received no volatile
anesthetic gas. Mean end-tidal concentrations of volatile anesthetic gas in the 22 donors who
received volatile anesthetic gas ranged from 0 to 1.25% with a mean end-tidal concentration of
M= 0.39%. Mean MAP in donors that did not receive volatile anesthetic gas was M= 78.49
mmHg (SD= 9.78 mmHg). Mean MAP in donors that received volatile anesthetic gas was M=
86.16 mmHg (SD= 7.02 mmHg). An independent samples t test performed between these two
groups demonstrated that the difference between mean MAPs of the two groups was statistically
significant (t= 2.182, p= 0.038), but no statistically significant correlation was found between
mean MAP and mean end-tidal volatile anesthetic gas (rs= -0.184, p=0.414).
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Conclusions: This study demonstrated that intraoperative hypertension is more prevalent than
intraoperative hypotension, and volatile anesthetic gas is often used at this medical center during
organ procurements at relatively low concentrations.
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Introduction
Background and Significance
Over 120,000 people are currently on the waiting list for organ transplants in the U.S.
according to data from the United Network for Organ Sharing (UNOS) as of April 17, 2016
(UNOS, n.d.). The vast majority of organ transplants come from deceased donors, and the
incidence of organ transplantation in the U.S. has increased substantially since its official
beginnings in 1988. However, during the past decade, deceased donor transplants have increased
approximately six percent, down from the decade before when donations had increased 31
percent according to data from the Organ Procurement and Transplantation Network (OPTN) as
of April 8, 2016. While the growth of transplantation has slowed, the number of patients waiting
for transplants has continued to climb, increasing 25.8% from 2005 to 2015 (OPTN, n.d). This
gap has created a shortage of suitable, available organs for transplantation. This shortage has led
to over 6,000 patients dying every year during the past decade while waiting for an organ
transplant (OPTN, 2016).
Several options have been proposed and trialed to increase the number of organs
available for transplant including extended criteria donors, splitting organs, increasing living
donors and donation after circulatory death, increasing donor registration, and organ perfusion
devices utilized after procurement prior to implantation (Saidi & Hejazii Kenari, 2014).
Optimizing the utilization of donor organs through better donor management preoperatively and
intraoperatively allows more organs to be transplanted per donor, thereby increasing the number
of patients being transplanted without an increase in the number of donors. Previous studies have
reported that blood pressure (BP) control and treatment is crucial to organ perfusion and can
greatly impact the quality and success of the transplant (Mukadam et al., 2005, Powner, 2005).
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Sandid, Assi, and Hall (2006) found intraoperative hypotension during cadaveric organ donor
procurement was an independent risk factor for slow kidney graft function in recipients (defined
as a decline in serum creatinine by less than 50 percent by day three).
Anderson, Bekker, and Vagefi (2015) assert that ―[t]he success of the anesthesiologist in
physiological optimization of the brain-dead donor may eventually determine the outcome of the
organ recipient‖ (p. 537). Additional research and dissemination of evidence on intraoperative
BP control in brain dead organ donors could increase the success of transplantation by
minimizing recipient graft function complications related to hypotension. ―Both initial and late
circulatory changes can lead to severe ischemic damage in donor organs before their removal,
causing deterioration of the quality of the transplanted graft‖ (Pratschke et al., 1999, p. 344).
According to McKeown, Bonser, and Kellum (2012), hypotension occurs in
approximately 81-97% of brain dead donors according to studies they reviewed. Conversely,
elevations in BP can also occur intraoperatively as demonstrated by the study by Wetzel, Setzer,
Stiff, and Rogers (1985). Ideal pharmacological treatment for BP derangements in brain dead
donors differ from intraoperative care of living patients due to the pathophysiological changes of
brain death and its sequelae.
Significant variations in practice exist among anesthesia providers in regards to
management of BP intraoperatively for brain dead organ donors. Many organ procurement
organizations (OPOs) provide donor anesthesia guidelines to anesthesia providers for the
procurement. Protocols for OPOs vary regionally, and many of these guidelines for BP
management lack evidence based in current research. For example, the 2015 consensus statement
on organ donor management by the Society of Critical Care Medicine, American College of
Chest Physicians, and the Association of Organ Procurement Organizations (Kotloff et al., 2015)
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B.C. Transplant, all still recommend dopamine as a first line agent for hypotension after the
donor has been fluid resuscitated. Kotloff et al. (2015) acknowledge dopamine as a first-line
agent, but that it only continues to remain a first-line agent due to a lack of evidence to change
the practice. Anesthesia providers’ adherence to guidelines is difficult to assess, and
intraoperative donor management is often subject to an anesthesia provider’s anecdotal
experience, as well as comfort with, and understanding of brain death.
Problem Statement
The cascade of brain death induces many physiological changes, which are wellestablished in the literature. As a result, brain dead organ donors cannot be managed the same as
living patients. Regulation of BP affects end-organ perfusion which is of key importance in
viability of an organ transplant. Although gaps remain in the literature that prevent development
of a comprehensive set of evidence based guidelines for BP management of brain dead organ
donors, anesthesia providers should be equipped with the current evidence and guidelines
available to manage BP in the setting of this unique physiology.
Anesthesia providers infrequently encounter organ procurements surgeries, resulting in
very little experience managing these unique physiological abnormalities. These procedures are
often urgently added during off-peak hours, leading to additional stress and little time for
preparation for an unfamiliar case. It is common for OPOs to provide the anesthesia team with a
sheet of guidelines for intraoperative donor management for the procurement surgery. However,
advisement and consensus of BP management during these surgeries is inconsistent and
controversial when comparing the available evidence and the published guidelines.
Purpose
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The purpose of this study was to examine intraoperative BPs and administration of
volatile anesthetics during brain dead organ donor procurement surgeries at a large medical
center in the U.S. that encounters a large number of organ procurements. Hypotension was
defined as a mean arterial pressure (MAP) less than 60 mmHg intraoperatively, and hypertension
was defined as a mean arterial pressure (MAP) greater than 90 mmHg intraoperatively. Use of
volatile anesthetics was examined to determine how use and dose affected the ability to maintain
MAP between 60 to 90 mmHg.
Hemodynamic stability is crucial to organ perfusion in order to prevent ischemia. Van der
Hoeven et al. (2000) suggest that maintaining normotension can limit the dysfunction of livers
from brain dead donors, and therefore greatly impacts the quality and success of the transplant.
Increasing availability and communication of necessary information to maintain hemodynamic
stability in brain dead donors, based on current research, will increase successful transplantation
by minimizing recipient graft function complications related to lack of donor BP control.
Clinical Questions
This study addresses the following research questions:


Given the negative impact of hypotension (defined as MAP less than 60 mmHg) on
transplanted organs, what has been the mean MAP and duration of intraoperative
hypotension during organ procurements at a hospital with a high volume of organ donors?



Is there a dose-dependent relationship between the intraoperative administration of volatile
anesthetics to brain dead organ donors and decreases in MAP?
Literature Review

Overview of the Literature Review Process
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A literature review was performed using PubMed, CINAHL, and WorldCat search
engines using the following terms: brain dead organ donor, brain dea*, organ donation,
intraoperative, management, anesthe*, hemodynamic, blood pressure, organ procurement,
organ harvest, and surgery. Recent relevant peer-reviewed literature, as well as pertinent historic
studies, related to managing both high and low BP, and the pathophysiology, proposed
mechanisms, and treatments during organ procurement surgery were reviewed. For the purposes
and scope of this literature review, interventions typically done in the intensive care unit (ICU)
setting, such as initial fluid resuscitation and hormone replacement such as corticosteroids and
thyroid hormones, were not included in the review. Adequate resuscitation and management
prior to the operating room (OR) are key for optimizing hemodynamic stability. Even with such
interventions to optimize hemodynamics prior to surgery, the BP variations intraoperatively
often pose the most frequent and significant challenges for the anesthesia provider and have the
potential to greatly impact the successful transplantation of organs in recipients.
Conceptual Framework
This study is guided by the Neuman’s system model (see Appendix B) for nursing
created by Dr. Betty Neuman. The Neuman’s system model’s core philosophy is rooted in basic
survival factors (Neuman, 2002). The response pattern to stressors is a key element of this
theory. Neuman describes a normal line of defense, which is the baseline level of wellness. The
model goes on to describe maintenance of the baseline level of wellness, as well as the lines of
resistance that are protective mechanisms that seek to stabilize the system after an insult and
return it to the baseline level of wellness. The theory focuses on optimal system stability and
variations of the optimal level of wellness. It defines the return and maintenance of system
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stability after treatment for stressor reactions as reconstitution, and emphasizes prevention as an
important intervention.
Neuman’s systems model can be directly applied to the physiological responses
demonstrated by brain dead organ donors in the OR (see Appendix C). The basic survival factors
as applied to the brain dead organ donor are organ strength or weakness. The process of brain
death breaches the normal line of defense, as the brain can no longer participate in maintenance
of homeostasis in the body. However, some lines of resistance remain. Neuman defines lines of
resistance as protective mechanisms that try to stabilize the system and reestablish wellness. The
spinal cord and lower autonomic nervous system can still discharge neural activity that can have
visible effects such as spinal reflexes and BP changes. These BP changes in the OR could be
viewed as a line a resistance, but with the brain not being able to participate in the feedback and
response functions, this line of resistance BP response becomes a dysfunctional response,
therefore it must be assisted or mitigated by intervention from the anesthetist.
Pathophysiology of Brain Death
Death has been defined in the U.S. through the Uniform Determination of Death Act
(UDDA):
[A]n individual who has sustained either (1) irreversible cessation of circulatory and
respiratory functions, or (2) irreversible cessation of all functions of the entire brain,
including the brain stem, is dead. A determination of death must be made in accordance
with accepted medical standards. (National Conference of Commissioners of Uniform
State Laws, 1980, p. 3)
The 1968 Harvard criteria has been the traditionally accepted medical standard for the
declaration of brain death in the U.S. It established that brain death is a permanent, irreversible
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coma. First, the patient must be unreceptive and unresponsive to external stimuli and inner
needs; for example, a lack of response to painful stimuli. Second, there must be no movement or
breathing, either spontaneously or in response to stimuli, and an apnea test should be performed
by removing the patient from mechanical ventilation for three minutes, allowing the carbon
dioxide to rise in the body, and observing for absent respirations. Third, the patient must have
absence of elicitable reflexes, including pupillary reflex, corneal reflex, oculovestibular reflex,
oculocephalic reflex, gag reflex, and not exhibit any posturing, blinking, swallowing, yawning,
vocalization, or tendon reflexes. The Harvard criteria recommend confirmation of an isoelectric
electroencephalogram (EEG), and repeating all tests after 24 hours to ensure no change.
Assessments and test validity require the patient not be hypothermic or have central nervous
system (CNS) depressants obscuring the clinical picture (Harvard Medical School Ad Hoc
Committee, 1968).
The most current criteria for the diagnosis of brain death are the 2010 American
Academy of Neurology (AAN) guidelines (see Appendix A). The AAN guidelines are the most
recent, comprehensive, evidence-based information available regarding the diagnosis of brain
death, and aim to provide the standard for brain death diagnosis. Universal acceptance of the
AAN guidelines for brain death diagnosis in all U.S. hospitals is still lacking.
Brain death, as it is defined in the U.S., involves the permanent cessation of function and
blood flow from the whole brain; however, persistence of spinal reflexes is a known, welldocumented phenomenon that occurs in some brain dead patients (Anderson & Bekker, 2015;
McKeown et al., 2012). Spinal reflexes can be spontaneous or elicited by noxious stimuli
(Pennefather, 1994), and reflexive activity from the spinal cord is thought to be the cause of
intraoperative hypertension (HTN) and increased catecholamine levels (McKeown et al., 2012).
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In brain dead patients, the herniation of the brain leads to total loss of parasympathetic activity,
resulting in unopposed sympathetic stimulation seen as HTN and tachycardia, and is referred to
as autonomic storm (Tuttle-Newhall, Collins, Kuo, & Schroeder, 2003). Catecholamine release
due to autonomic storm at the time of brain stem herniation causes organ ischemia. Systemic
vascular resistance is elevated greater than the elevated perfusion pressure (Tuttle-Newhall et al.,
2003). After this surge comes a massive decrease in sympathetic outflow (Pratschke et al., 1999),
causing loss of vascular tone, and therefore profound hypotension leading to cardiovascular
collapse in many patients (Bugge, 2009).
After brain death, although the spinal cord is not in communication with the brain, it can
play a role in catecholamine release. Catecholamine release can be triggered via stimulation of
the adrenal medulla, similar to spinal cord-transected, quadriplegic patients who experience
autonomic dysreflexia, where uncontrolled sympathetic outflow is unopposed by the
parasympathetic nervous system (Wetzel et al., 1985). Pennefather, Dark, and Bullock (1993)
found significant hemodynamic changes in brain dead donors during organ procurement surgery
and measured increased catecholamine levels intraoperatively. Surgical stimuli may initiate
spinal reflexes and reflexive sympathetic discharge from the spinal cord alone.
Incidence of Blood Pressure Derangement in Brain Death
According to McKeown et al. (2012), hypotension occurs 81-97% of the time in brain
dead donors due to the loss of sympathetic tone, diabetes insipidus-related hypovolemia from
brainstem herniation, as well as the reduced coronary blood flow and myocardial stunning from
excessive catecholamine discharge at the time of brain death. It is important to note that Bijker et
al. (2007) found that there is not a standard definition of intraoperative hypotension. Some
studies define it as a decrease in systolic or MAP below an absolute threshold and others define

INTRAOPERATIVE BLOOD PRESSURE

14

it as a decrease relative to the baseline BP. Within those definitions, the degree and duration of
BP decrease varies as well. This variation in definitions makes it more difficult to understand the
true incidence of intraoperative hypotension and how it is associated with adverse outcomes.
Wetzel et al. (1985) documented heart rate (HR) and BP changes that occurred during
surgery for organ donation in ten brain dead donors.
Elevations above baseline occurred within the first minute after incision and maximum
responses were seen between five and 20 min. These peak changes in blood pressure and
heart rate were reached before aortic cross clamping or the occurrence of any other
surgical procedure that could be expected to mechanically elevate blood pressure or cause
an increase in heart rate. (p. 126)
The mean increase in systolic BP was 31 torr and diastolic pressure increased by a mean of 16
torr. HR increased by a mean of 23 beats per minute. All donors in this study who were being
maintained on vasopressor infusions prior to entering the OR were able to have dosages of those
infusions decreased or stopped. Additionally, every donor demonstrated a return to baseline BP
within 25 minutes of incision (Wetzel et al., 1985).
Anesthesia and Hemodynamic Responses
The work by Wetzel et al. (1985) led to experiments to test the blunting of this
hemodynamic response to surgical stimulus in brain dead patients. Fitzgerald et al. (2003) found
the use of fentanyl, at a dose of seven micrograms per kilogram, was not effective in suppressing
catecholamine release from surgical stimulation in brain dead organ donors. Serum
catecholamine concentrations rose following noxious stimuli, however there were no differences
in the hemodynamics in the group that received fentanyl versus the group that received the
placebo. Investigators in this study noted that serum concentrations of epinephrine, but not
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norepinephrine, were actually higher in the group that received fentanyl. Epinephrine levels were
highest after sternotomy demonstrating that not only do opioids lack the ability to attenuate
hemodynamic responses in brain dead organ donors, but also fail to mitigate the catecholamine
discharge intraoperatively (Fitzgerald et al., 2003).
Antognini and Berg (1995) investigated the extent of the brain’s role in suppressing
hemodynamic responses to noxious stimuli under isoflurane anesthesia. In this animal study,
they were able to isolate delivery of isoflurane to the brain in one group and isolate delivery to
the spinal cord in the other group. Those groups were compared to isoflurane delivered to the
whole body. They found that isoflurane delivered to the whole body does prevent hemodynamic
responses to noxious stimuli, but profoundly lowers the MAP. Furthermore, by comparing the
brain-only and spinal cord-only groups, the researchers found that the brain has very little control
over the hemodynamic response to noxious stimuli as the minimal alveolar concentration to
block autonomic response (MAC-BAR) was significantly greater in the brain-only group
compared to the MAC-BAR in the whole body group.
Some studies have demonstrated potential tissue protective benefits in from
preconditioning with volatile anesthetics such as isoflurane and led to some use of volatile
anesthetic in the brain dead donor population, but a review by De Hert, Turani, Mathur, and
Stowe (2005) concluded that none of the studies ―unequivocally demonstrate that the use of a
volatile anesthetic regimen resulted in a clinical benefit for the patients‖ (p. 590).
Several guidelines, including the 1999 recommendations from the Intensive Care Society
of the United Kingdom (U.K.), state that anesthesia is not necessary for brain dead donor organ
procurement operation (Morgan, Morgan, & Smith, 1999). Withholding anesthesia is the
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standard in many places including the U.S., but it not universal and the risks and benefits of
volatile anesthetics in brain dead donors continues to require further research.
Boutin et al. (2012) analyzed the differences in brain dead donors in France who had
received anesthesia versus those who had not. Anesthesia, defined as at least one dose of
hypnotic agent, anesthetic gas, or opioid, was received by 62% of donors. Donors who did not
receive anesthesia maintained a MAP greater than 65 mmHg more frequently than donors who
received anesthesia. Additionally, no difference in maximum MAP was found between the two
groups. Donors in this study who received anesthesia required more fluid challenges and
vasopressors and exhibited higher heart rates (HRs) and lower BPs. Data from this study does
not support the use of anesthesia to control intraoperative HTN.
Management of Hypertension
Some have argued that volatile anesthetics can and should be used in brain dead organ
donors to control intraoperative HTN; however, evidence is lacking (Boutin et al., 2012). The
1999 recommendations from the Intensive Care Society in the U.K. state that although anesthesia
is not necessary for brain dead organ donors, volatile agents can be used to manage HTN
(Morgan et al., 1999). Available evidence suggests volatile anesthetics are a greater detriment
than potential benefit due to the lowering of BP and therefore decreased end organ perfusion.
Intraoperative HTN can be transient due to increases in catecholamines from sympathetic
stimulation, thus most recommendations for treatment of HTN in brain dead organ donors
suggest administering short-acting agents to control HTN. The risk of organ damage with HTN
occurs when the BP exceeds the upper limit of autoregulation. Powner, Darby, and Kellum
(2004) recommend conservative treatment of HTN. Initial HTN interventions should include
decreasing or stopping vasopressor infusions. They suggest initiation of antihypertensive therapy
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after MAP has been greater than 95 mmHg for 30 minutes, with a goal of MAP less than 90
mmHg, but above 65-70 mmHg. Additionally, the authors recommend labetalol 20 milligrams
IV bolus every 20 minutes times two doses titrated to the goals above. If MAP is still not within
the goal parameters, a nicardipine infusion is recommended starting at five milligrams per hour
and titrated for the goals above, up to a maximum infusion rate of 15 milligrams per hour.
Although Anderson et al. (2015), acknowledges HTN related to autonomic storm can be
managed with nitroprusside or esmolol, they state that autonomic storm during brain herniation
is not an issue in the OR after time has elapsed since herniation, diagnosis of brain death, and
consent for donation. The authors fail to address anesthetic management of HTN intraoperatively
in their narrative review of anesthetic considerations in organ procurement surgery.
Likewise, Arbour (2005) also recommends treating autonomic storm with esmolol and
nitroprusside. Most donor management literature focuses on interventions during and after brain
death declaration in the ICU and neglects the intraoperative phase. Donor management
guidelines for the ICU can be extrapolated to the OR; however, it can be argued that the
physiology issues present when treating autonomic storm at the time of brain death differ from
the physiology issues of treatment of intraoperative HTN in the brain dead organ donor. The
principles of choosing drugs with short onset and duration as well as ability to titrate (Arbour,
2005) may be helpful in either situation.
Management of Hypotension
More studies are available regarding management of hypotension in brain dead donors
compared with management of HTN. The literature is heavily focused on the ICU management
rather than intraoperative management, but significant crossover exists. Literature pertaining to
fluid management goals in the ICU, hormone replacement protocols, and corticosteroids were
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not included in this review as those interventions are typically completed during donor
management in the ICU. Proper fluid resuscitation to euvolemia is the standard for organ
procurements, and without adequate fluid resuscitation, intraoperative management options may
be less successful.
Traditionally, cerebral blood flow autoregulation between a MAP of 60 and 160 mmHg
has been used a benchmark for intraoperative BP management, with the knowledge that things
like chronic HTN can shift this curve. Most tissues in the body are able to autoregulate blood
flow to some extent (Butterworth, Mackey, & Wasnick, 2013). Ono et al. (2013) found that acute
kidney injury was independently associated with excursions of MAP below the lower limit of
cerebral blood flow autoregulation. Additionally, Rhee et al. (2012) found that renal blood flow
decreased incrementally below baseline perfusion pressure much earlier than cerebral blood flow
decreased in the setting of hemorrhagic shock. Failure to correct hypotension can lead to acute
kidney injury (Lange & Souter, 2015).
Hemodynamic management should focus on the goals of restoring euvolemia,
maintaining adequate perfusion pressure, and optimizing cardiac output (Lange & Souter, 2015).
Literature reviewed recommended maintaining hemodynamic stability with a goal of a MAP of
60-90 mmHg.
When hemodynamic instability in the brain-dead donor is not corrected, kidney
dysfunction is enhanced and immune activation occurs faster and is more profound. The
observed changes may predispose the graft for additional ischemia/reperfusion injury
during the transplant process and hence accelerate rejection of the graft after
transplantation. (van der Hoeven et al., 2003, p. 1874)
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Additionally, van der Hoeven, et al. (2000) states that progressive liver dysfunction is
significantly worse in rats that were hemodynamically unstable (defined as MAPs of 55  5.3
mmHg one hour after brain death and 52  9.9 mmHg six hours after brain death) with increased
immune activation also being present in these situations.
After proper fluid resuscitation, if MAP is less than 65 mmHg, dopamine has
traditionally been the first-line vasopressor recommended for management of hypotension in
brain dead organ donors (Bugge, 2009). Dopamine may offer protective effects against ischemiareperfusion injuries and inflammation by enzyme induction of heme-oxygenase-1 and other
enzymes. Bugge (2009) found that catecholamine use in donors may have some benefit in fouryear graft survival rates for kidney transplantation. Norepinephrine increased the incidence of
initial non-function in heart recipients, but did not negatively affect liver grafts. The author notes
that the study was retrospective therefore causality could not be determined. Bugge (2009) also
indicates use and avoidance of specific vasoactive medications in donors are varied and lack
evidentiary consensus, as there is a lack of randomized controlled trials.
Mukadem et al. (2005) demonstrated catecholamine use (defined in this study as
dopamine at 2.5 mcg/kg/min or greater, epinephrine, or norepinephrine) was associated with
worsening gas exchange after lung transplantation. Zaroff et al. (2002) proposed a strict protocol
for limiting the maximum dosages of catecholamines in brain dead donors in order to facilitate
better outcomes for heart transplants as high-dose catecholamine infusions have been thought to
cause downregulation of beta adrenergic receptors, depletion of norepinephrine and high-energy
phosphates in the myocardium. Silva et al. (2002) found that primary graft failure for heart
transplants was not increased in when donors had been maintained on high-dose catecholamine
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infusions in order to maintain a MAP 70-100 mmHg, suggesting that organ perfusion pressure is
important than adherence to maximum suggested dosages.
Studies have shown successful hemodynamic management with both norepinephrine and
vasopressin after adequate fluid resuscitation and dopamine infusion (Bugge, 2009). Practice of
vasopressor management varies widely since there is a lack of evidence to recommend use or
avoidance of any one vasopressor over another other than based on clinical presentation of the
donor (Westphal et al., 2012).
Studies establishing and examining the BP alterations encountered in brain dead donors
during organ procurement are decades old. This study provides an update on intraoperative BP
derangements in brain dead organ donors. Additionally, much of the available evidence to
potentially support the argument for use of volatile anesthetics in brain dead organ donors is
extrapolated from animal studies. This pilot study examines the effects of volatile anesthetics on
BP during procurement surgery for brain dead organ donors.
The evidence table (Table 1) provides a summative overview of the main studies
reviewed in the literature review section regarding the available evidence about the
intraoperative blood pressure variations and the effects of anesthesia in brain dead organ donors.
Methods
Research Design
This study employed a retrospective chart review to analyze intraoperative BP
management of brain dead organ donors. MAPs were collected every minute. Presence or
absence of the administration of volatile anesthetic gas in the OR was collected. Type of volatile
anesthetic administered and end-tidal concentrations of the volatile anesthetic gas were also
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collected. The study was designed to examine intraoperative hemodynamic stability and further
investigate the effects of volatiles anesthetic gas on brain dead donors during organ procurement.
Sampling and Setting
Institutional review board (IRB) approval from both DePaul University as well as
Advocate Christ Medical Center (ACMC) was obtained prior to data collection. Standard Health
Insurance Portability and Accountability Act (HIPAA) regulations were followed to protect
donor and donor family anonymity as described later in the data collection section. Intraoperative
records were reviewed from organ donor procurement surgeries from May 1, 2015 through April
30, 2016 at ACMC, in Oak Lawn, Illinois. This yielded 28 individual cases.
ACMC is a level one trauma center in the near southwest suburbs of Chicago. This
facility has been the focus of media attention in recent years due to the high volume of traumas
and the high rates of violence in certain parts of Chicago. ACMC was chosen as the study site
because it regularly encounters a high number of organ donors.
Study
Inclusion criteria


All brain dead organ donors age 15 and older who reached the OR at ACMC between May 1,
2015 through April 30, 2016
Exclusion criteria



Donations after cardiac death



Donors that cardiac arrest prior to reaching the OR and therefore no organs are procured



Brain dead organ donors age 14 and under

Instruments for Data Collection
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Data was collected from the intraoperative records at ACMC which used the Cerner
SurgiNet charting system at the time of this study. BPs were automatically saved to the
intraoperative anesthesia record from the patient monitor. The standard procedure for BP
monitoring for brain dead organ donors at ACMC and by the local OPO is to monitor BPs from
an existing arterial line, typically placed in the femoral artery. MAPs recorded for this study
were taken from the arterial line pressure at one minute intervals and automatic BP cuff readings
when available. Data collected includes:


MAPs documented in the anesthesia record at one minute intervals



Total number of minutes in the OR (defined as starting at first recorded BP to last
recorded BP before aortic cross clamp)



Administration and end-tidal concentrations of volatile anesthetic gas such as
sevoflurane, isoflurane, and desflurane

Ethical Considerations
Federal regulation 45 C.F.R. §46.102 (US Department of Health and Human Services,
2009) defines a human subject as a "living individual about whom an investigator (whether
professional or student) conducting research obtains (1) Data through intervention or interaction
with the individual, or (2) Identifiable private information" (p.4). Research involving deceased
human subjects does not meet the criteria for research with human subjects according to the law.
Patients who are declared brain dead meet the medical and legal criteria for death.
Although the subjects in this study do not meet the criteria for human subjects, it was still
essential to protect their private health information. The medical record numbers (MRNs) were
the initial identifiers of the cases to determine if the donor met inclusion criteria for this study.
This information was protected as described below in the data collection section. Sensitive
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details surrounding the medical history and manner of death were not included in this chart
review. No identifiable information, such as the date of the surgery, age, or date of birth was
recorded for this study.
Data Collection
The data gathered in this chart review included MAP BP readings, as well as use of
volatile anesthetic gas and their end-tidal concentrations. Patients should not be able to be
identified from this information; however, patients were initially be identified by MRN by the
medical records department at ACMC. One Excel spreadsheet was made with the MRN and
assigned subject number without any other potential patient identifier. The data sheet was stored
in a password protected spreadsheet on a password protected laptop computer that is locked in a
safe in the primary investigator’s (Alison Karmanian) home office when unattended. A second
Excel spreadsheet was used to store the data collected on MAPs and volatile anesthetic gas with
only the subject number identifying the patient. The data collection spreadsheet did not have any
information that could identify the subject and consisted of gathering data that already existed;
therefore, the study was exempt from the Common Rule (US Department of Health and Human
Services, 2009). The MRN, nor any other identifiable patient information, was not disseminated
to committee members or included in the study and report in compliance with HIPPA rules.
Results
Twenty-eight cases met the inclusion criteria, and data was analyzed using International
Business Machines (IBM) SPSS version 24 (IBM, 2017). Statistical significance was set
at p value of ≤ 0.05 for all inferential statistics.
Mean MAP was calculated for each donor. Mean MAPs ranged from 61.04 to 99.34
mmHg with a mean of M= 84.51 mmHg (Figure 1). Twenty-two donors (78.6%) received

INTRAOPERATIVE BLOOD PRESSURE

24

volatile anesthetic gas at some point in the anesthesia record. Six donors (21.4%) received no
volatile anesthetic gas. Mean end-tidal concentrations of volatile anesthetic gas in the 22 donors
who received volatile anesthetic gas ranged from 0 to 1.25% with a mean end-tidal concentration
of M= 0.39% (Figure 2). Sevoflurane was used in 17 donors, and isoflurane was used in 5
donors.
Mean MAP in donors that did not receive volatile anesthetic gas was M= 78.49 mmHg
(SD= 9.78 mmHg). Mean MAP in donors that received volatile anesthetic gas was M= 86.16
mmHg (SD= 7.02 mmHg). Equal variances of the groups were examined using the Levene’s test,
and revealed homogeneity. Independent sample t test revealed a statistically significant
difference between mean MAPs of the two groups (t= 2.182, p= 0.038).
The Spearman’s rho correlation coefficient (rs) was used to determine the relationship
between mean MAP and mean end-tidal concentration of volatile anesthetic gas in donors in this
study because mean end-tidal concentrations were not normally distributed. There was no
statistical significance (p=0.414) found for the weak negative linear correlation (rs= -0.184)
between mean end-tidal concentration and mean MAP.
Discussion
This single-center pilot study at a large teaching hospital and transplant center that
performs a high volume of organ donors was conducted to determine mean MAP and duration of
intraoperative hypotension during organ procurement operations. Available literature on
recommendations for MAP goals in organ donors suggest that a MAP between 60-90 mmHg is
optimal (Kotloff et al., 2015, McKeown et al., 2012, Powner, 2005, Powner et al.,
2004,Westphal et al., 2012, Zaroff et al., 2001). Mean MAPs for donors in this study during the
organ procurement operation ranged from 61.04 to 99.34 mmHg with a mean of 84.51 mmHg.
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On average, BP of donors was managed in a way that MAPs fell within this optimal range. In the
28 donors included in this study, no donor demonstrated an average MAP below 60 mmHg. Five
donors did have an average MAP greater than 90 mmHg, indicating that intraoperative
hypertension is a more prevalent problem than intraoperative hypotension.
The majority of donors (22 out of 28, or 78.6%) in the study received volatile anesthetic
gas at some point during the organ procurement. Available literature states that anesthetics, such
as volatile anesthetic gas, are not necessary for this procedure as donors are brain dead (Boutin et
al., 2012, Morgan et al., 1999). It was found in this study that administration of volatile
anesthetic gas during organ procurement is a very common occurrence at this medical center.
Although published data and rationale on using volatile anesthetic gas in this population is
limited, the rationale of blocking sympathetic blood pressure response to incision is commonly
cited (Antognini & Berg, 1995, Elkins, 2010, Yoo et al., 2008, Young & Matta, 2000). The
clinical dose of volatile anesthetic gas needed to suppress this response in 50% of patients is
referred to at the minimum alveolar concentration to block adrenergic response (MAC-BAR)
(Barash et al., 2013). MAC-BAR is estimated at 50% higher than minimum alveolar
concentration (MAC) (Barash et al., 2013). The MAC of sevoflurane is 1.8% end-tidal
concentration, and the MAC of isoflurane is 1.17%, which makes MAC-BAR for sevoflurane
2.7% and MAC-BAR for isoflurane 1.76%. The highest mean end-tidal concentration of volatile
anesthetic gas for a donor in this study was 1.25% which falls well below MAC-BAR for either
volatile anesthetic gas used in this study (sevoflurane was used in 17 donors, and isoflurane was
used in 5 donors).
Mean MAP was higher in donors who received volatile anesthetic gas (86.16 mmHg 
7.02 mmHg) than in donors who did not receive it (78.49 mmHg  9.78). Volatile anesthetic
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gases all share a common side effect of causing dose-dependent hypotension via peripheral
vasodilation (Barash et al., 2013). Therefore, it would be natural to expect donors who received
volatile anesthetic gas to display lower mean MAPs, but this is not what was found in this study.
It could be inferred that volatile anesthetic gas was being used to assist in controlling BP in
donors who exhibited high BP intraoperatively during procurements. Volatile anesthetic gas is
very convenient and easy to start, stop, and titrate, and anesthesia providers are likely most
comfortable with this method of augmenting high blood pressure as this is often a first-line agent
used for controlling an increasing BP in the operating room for most standard surgical cases.
An independent samples t test between donors who received volatile anesthetic and those
who did not determined that the difference in mean MAPs between the two groups was
statistically significant (p= 0.038).
The Spearman correlation coefficient (rs) was also performed and determined that there
the weak negative relationship between mean MAP and end-tidal concentration of anesthetic gas
was not statistically significant. Interestingly, as noted above, low means were more related to
low end-tidal concentrations of volatile anesthetic gas, contrary to what the literature states about
the dose-dependent hypotensive effects of volatile anesthetic gas. This seems to indicate that
anesthesia providers may be implementing use of volatile anesthetic gas more in donors that are
demonstrating intraoperative HTN than those who are not.
Other medications that affect BP were not recorded as part of this study which poses a
significant limitation. Due to the physiological processes that occur during and after brain death,
vasopressor support with infusions is common. Additionally, anesthesia providers commonly
administer intravenous boluses of vasopressors to titrate BP to ideal levels. Antihypertensive
agents could also be administered in the operating room and would confound the BP variability.
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In addition to use of these infusions and boluses of medications that can alter BP, availability of
this information in the electronic anesthesia medical record is dependent on the user accurately
recording the drug, dose, and time of administration. In the future, smart pumps and medication
scanning in the operating room may help improve the accuracy of medication administration
intraoperatively.
The MAP and end-tidal concentrations of volatile anesthetic gas are automatically
recorded from the equipment directly in the electronic anesthesia record. In this specific
electronic anesthesia record system, this data is able to be changed by the user in a different
screen. Additionally, aberrant readings from the arterial line which records the blood pressure
may be automatically documented on the record (such as when blood is being drawn from the
line or when the line is being flushed). The transducer of the arterial line must be calibrated
correctly in order to obtain accurate readings of arterial BP. There is not a way to verify that this
was done in the cases examined for this retrospective chart review. When recordings from the
arterial line were not available in the anesthesia record, non-invasive blood pressure cuff MAP
values were used instead. If systolic BP and diastolic BP were documented in the record, but the
MAP value was not present or was clearly aberrant (greater that the systolic BP value), MAP
was calculated by the primary investigator of the study.
During data collection, different patterns of volatile gas administrations were observed
including the use of volatile anesthetic gas only around incision time, as needed, throughout the
entire procedure, choice of volatile anesthetic gas (sevoflurane and isoflurane were both used),
and use of no volatile anesthetic gas. Provider preference may have an impact on the use of
anesthetic gas and potentially the pattern of use, but the anesthesia providers for the cases were
not recorded as part of this study.
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Several other details may impact the intraoperative blood pressure of brain dead organ
donors including medical conditions such as cardiogenic shock or supportive therapies such as
intra-aortic balloon pumps or extracorporeal membrane oxygenation, co-morbidities, age, and
cause of death. With only 28 donors identified for this study, collection of any of the above
information could potentially identify a particular donor and therefore, these details were
deliberately excluded from data collection, despite their potential significance.
Patients were identified for this study through the billing department of the hospital
which keeps a log of all organ donor cases. Identification of appropriate candidates was entirely
dependent on the accuracy of this list.
Additional intraoperative event time would be helpful to collect in future studies
including incision time, sternotomy time, and aortic cross-clamp time.
Future studies should be done comparing recipient outcome data to intraoperative BP and
the use of volatile anesthetic gas. More detailed data may be able to determine which organs may
be more sensitive to the effects of low or high BP during organ procurement and may provide
some insight on autoregulation of blood flow to organs in brain dead patients. Future prospective
studies may benefit from observation and data collection of vital signs and medication
administration in real time to minimize documentation errors.
Conclusion
This retrospective review of records among brain dead organ donors aged 15 and older
demonstrated that intraoperative HTN is more prevalent than intraoperative hypotension.
Volatile anesthetic gas is often being used at this medical center during organ procurements at
relatively low concentrations. There was a statistically significant difference (p= 0.038) between
mean MAPs in donors who received volatile anesthetic gas versus those who did not, and there
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was no significant relationship found between mean MAP and end-tidal concentration of volatile
anesthetic gas.
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Table 1
Evidence-based Table on the Intraoperative Blood Pressure and Effect of Volatile Anesthetic in
Brain Dead Organ Donors
Author/
Year

Design/
Method/
Sample/
Setting

Key Findings

Appraisal Relevant
to the DNP Project

Bugge (2009)

Review

-review evaluates current
practice against current
research
-HD management plan
describes order of
interventions and
discusses HD monitoring
options

Mukadam et al.
(2005)

Retrospectively
analyzed,
prospectively
collected data of
60 lung donors
and recipients;
categorized to
treatment or

-sustained hypotension associated with
impaired graft function
-80-90% require vasopressor or inotropic
support
-vasoactive medication use not based on
randomized controlled trials; widely
divergent opinions on best to use and avoid
-adequate coronary perfusion pressure may
be more important than avoiding high-dose
catecholamines
-dopamine is traditional first choice pressor
-dopamine may induce protective enzymes
(HO-1) to guard against ischemia/
reperfusion injury and inflammation
-dopamine maximum of 10 mcg/kg/min
lacks good evidence
-dopamine should be titrated to target
hemodynamic effect (due to individual
differences in pharmacodynamics) with the
limitation of tachycardia
-after fluid resuscitation and dopamine,
both norepinephrine and vasopressin have
been used successfully
-vasopressin good for DI and decreases
catecholamine use
-norepinephrine in mammals increases
coronary and RBF
-norepinephrine is related to primary graft
dysfunction and decreased right ventricle
contraction and 1-year survival for heart
transplant (retrospective, therefore not
causal)
-volatile anesthetics still experimental, but
may protect heart from ischemia/
reperfusion injury
-catecholamine use was associated with
worse gas exchange after transplantationdifference not related to ischemic time,
preservation technique, or recipient donor
-donors requiring catecholamines may have
had more severe AS and therefore more
pulmonary injury and inflammation.
-if catecholamines were needed for CV

-different organs respond
differently to
catecholamines with
some gaining protection
and others demonstrating
worsened outcomes- a
balance that must be
struck with donor
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Boutin et al.
(2012)

Young and
Matta (2000)

Kotloff et al.
(2015)

control group by
what they
received and
compared PaO2/
FiO2 ratios
Multicenter
retrospective
study of records
of BD patients;
data collected
includes
extended criteria
donor status,
resuscitation
duration and
procedures,
period of brain
death, cold
ischemic time,
type of
anesthesia,
hemodynamic
and ventilatory
parameters, and
impact of
anesthesia on
renal graft
Expert opinion

Consensus
statement;
multidisciplinary
, multiinstitutional task
force divided in
subcommittees;
available
literature
comprised of
mainly
observational
studies and case
series (low
quality evidence)
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function, it could exacerbate left atrial
pressure

management

-62% of donors in study received anesthesia
-donors who did not receive anesthesia
maintained a MAP >65 more frequently
with no difference in maximum MAP
-those who received anesthesia required
more fluid challenges, (especially with
colloids) and pressors, had lower MAPs and
higher HRs
-persistence of partial spinal regulation in
BP and temperature
-reports increased HR and BP in 24% of
subjects who received no anesthesia
-tissue protective effects of opioids are not
justified by research, and there is very
limited info on the tissue protective effects
of volatile anesthetic agents

-anesthesia 
hypotension  poor graft
function
-anesthesia showed no
difference in maximum
MAP
-the use of anesthesia to
control intraoperative
HTN is not supported by
the data in this study
-anesthesia increases
incidence of hypotension
and does not control HTN

-different definitions of brain death in
different countries (whole brain versus
brain stem)
-Intensive Care Society of U.K. 1999
recommendations say anesthesia not
necessary for BD donors, but HTN can be
managed with nitroprusside or a volatile
agent
-argues for anesthesia for hemodynamic
response to surgery and persistence of
higher brain & spinal cord function in some
donors & inability to test reticular
formation
-HD management recommendations:
 hypovolemia frequently present at BD
and should be corrected quickly
 HD monitoring tools are helpful in
assessment of volume status and response
to therapy.
 PAC, CVC, or noninvasive monitors
should be considered for serial &
continuous measurement
-fluid resuscitation guidelines: MAP ≥60,
UO ≥1cc/kg/hr, EF at least 45%, lower
vasopressor dose (e.g. dopamine ≤
10mcg/kg/min)
-goal directed fluid therapy with goal of
euvolemia recommended for entire

-different definitions may
impact physiology and
therefore donor
management, so
management
recommendations cannot
necessarily be generalized
to the international
community

-their literature review
revealed low quality
evidence therefore paper
is termed consensus
statement versus
guidelines
-ICU recommendations
can likely be extrapolated
to OR management
-euvolemia
-specific parameters for
goal-directed therapy and
recommendations for HD
monitoring
-use of vasopressin
associated with increased

INTRAOPERATIVE BLOOD PRESSURE

Barash et al.
(2013)

Textbook

Anderson et al.
(2015)

Narrative review

McKeown et al.
(2012)

Review

management phase
-HES should not be routinely used due to
issues with AKI, coagulopathy, trapping in
hepatic reticuloendothelial system, and is
associated with delay graft function/ failure
-low molecular weight HES may be safer,
but not currently recommended
-crystalloid & colloids ok
-dopamine is the traditional first-line
vasoactive agent; insufficient data to
recommend others over dopamine
-dopamine has protective effects
-vasopressin is alternate 1st line agent;
additional pressor for refractory shock
-norepinephrine, phenylephrine, and others
may be used in severe shock (dobutamine,
dopamine, and epinephrine for primary
pump dysfunction; norepinephrine and
phenylephrine for vasodilatory shock/low
SVR)
-if HD goals still unmet and/or EF <45%,
HRT is recommended
-BD donors present many challenging
management issues because collected
experience in a single center is usually
small, and research in brain-dead human
subjects is sparse
-there is solid evidence that desmopressin is
better than norepinephrine for maintaining
quality of donor hearts
-mainstay of donor management is
maintenance of euvolemia; CVP monitoring
standard (maintained 6-12); PCWP <12
when PAC used
-goals of volume resuscitation and HR are
to minimize pressors as high-dose
dopamine associated with renal graft failure
-intraoperative management may affect
recipient outcomes
-dramatic loss of sympathetic tone can
result in HDI
-evaporative loss
-incisional blood loss
-polyuria secondary to DI
-AS not encountered in OR, but managed
with nitroprusside and esmolol
-avoid HES
-arterial pulse pressure variation can guide
fluid therapy
-if lung procurement, colloid preferred
-increasing consensus in donor management
guidelines, but lacking controlled
evaluation of many of the specific
components of donor management
-optimal treatment combinations not
established and more research needed
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rate of organ recovery
-recommendations for
which vasoactives for
which scenarios

-vasopressin better than
norepinephrine for hearts
-CVP 6-12
-POAP when available
<12
-goal: minimize use of
pressors  balance good
end-organ perfusion by
using pressors only when
necessary to minimize
deleterious effects

-dopamine 5 mcg/kg/min
improves blood flow to
renal, mesenteric, and
coronary vascular beds 
enhances organ perfusion
-dopamine versus
norepinephrine; evidence
lacks superiority of one
over the other
-avoid high-dose alpha
agonists  decreased
blood flow and O2
delivery
-hormonal resuscitation
as discussed in the UNOS
critical pathway for the
organ donor in 1999
showed a 1% increase in
organs retrieved from BD
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Elkins (2010)

Literature review

Fitzgerald et al.

Randomized,

-incidence of hypotension in donors: 8197%
-Crystal City Consensus Conference
Cardiac Recommendations
-Canadian multidisciplinary forum on donor
management: HR 60-120, SBP >100,
MAP≥70
-rule of 100s (SBP, UO, PaO2, Hgb)
-vasopressin 0.5-2.4 units/hr may decrease
catecholamine requirements
-high-dose norepinephrine
(>0.05mcg/kg/min) should be avoided if
possible
-multicenter clinical trial underway to
determine if fluid management protocol via
pulse-pressure variation can increase
viability of lungs and other organs
-vasopressin recommended as 1st line agent
by Canadian guidelines
-HR looked good when initial studies were
compared to historic controls, but
randomized studies failed to show benefit
-in one study, untransplantable hearts were
resuscitated during surgery and improved
-CV response is generated and modifiable
at the level of the spinal cord alone
-spinal reflexes can occur spontaneously or
with surgical stimulus  NMB
-surgical manipulations can cause CV
instability
-several randomized donor intervention
studies are in progress
-treatment of AS with emolol, nicardipine,
and urapidil in 2006 study
-Arbour (2005) recommends esmolol and
nitroprusside as effective and short-acting
agents for HTN
-BD causes decreased CO and increased
SVR
-thyroid supplementation improved CO and
SVR  increased tissue perfusion &
oxygenation; decreased lactic acidosis
-CV stimulation is believed to involve a
reflex arc to the adrenal medulla and may
be increased by excitation of spinal cord
below the lesion
-1.5% isoflurane 20 minutes prior to
ischemia (animal study by Hashiguchi et al.
(2005)); significantly lower BUN and
creatinine at 24 and 48 hours after
transplantation/ reperfusion
-isoflurane, xenon, nitrous oxide at 0.43%
MAC suppress effects of TNF-α on certain
gene and protein expression that can
damage endothelium
-use of fentanyl 7 mcg/kg was not effective
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donors, but a 19.5%
increase in hearts
transplanted
- pilot study donors were
younger and less likely to
have had strokes and
other comorbidities; more
data needed

-pathophysiology similar
to autonomic dysreflexia;
uncontrolled sympathetic
outflow
-catecholamines trigger
inflammatory response
and ischemia  acute
rejection
-more research needed on
ischemic preconditioning
in donors
- literature suggests
strongly that AS causes
deterioration of organs,
therefore preventing
sympathetic surge
intraoperatively due to
surgical stimulation could
increase likelihood of
successful transplant

-opioids have shown to
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(2003)

placebocontrolled,
double-blinded
study (n=17)

Wetzel et al.
(1985)

Retrospective
chart review of
10 donors
Quasiexperimental
(group I
isoflurane to
torso, group II
isoflurane to
cranial, wholebody
administration of
isoflurane)

Antognini and
Berg (1995)

in suppressing the catecholamine release,
following painful surgical stimulation in
BD organ donors
-catecholamine concentrations rose
following painful stimuli
-no differences in hemodynamics between
the fentanyl and the placebo group
-epinephrine concentrations, but not
norepinephrine, were higher in the fentanyl
group, reaching significance following
sternotomy
-SBP increased by a mean of 31 mmHg,
DBP by 16mmHg, and HR by 23 bpm in
response to surgical stimulation
-theorized that during isoflurane anesthesia,
CV responses to noxious stimuli were
generated in the spinal cord
-at ~1 MAC, MAP changes for Group II
were much smaller than MAP for the
whole-body
-for whole-body administration of
isoflurane, MAP change was 42  20
mmHg for MAC values at 1.0  0.1
-MAP change for Group II was 12  9
mmHg at 1.1  0.4 MAC
-there was decreased response in MAP to
the noxious stimulus in Group II,
suggesting an inhibitory response

Powner (2005)

Review

-goal: maintenance of MAP > 60
-there is little evidenced-based data that ties
specific hemodynamic variables with
outcomes after heart transplant

Powner et al.
(2004)

Guidelines
synthesized from
articles in
Progress in
Transplantation
that outlined
treatment issues
in donor care

Zaroff et al.
(2001)

Consensus
statement/ expert
opinion

-HTN: conservative treatment
recommendations; goal: MAP <90, but
>65-70
-therapy should start at MAP>95 x 30
minutes or more
-hypotension (MAP<60): different kinds of
shock; in BD, loss of vasomotor centers in
brain  vasodilation; decreased cardiac
contractility; hypovolemia due to DI;
treatment goal: MAP 65-75
-adjust inotropes to maintain MAP ≥60
-target dopamine or dobutamine <
10mcg/kg/min

Van der
Hoeven et al.

Randomized
controlled trial

-the hypotensive group remained
hypotensive after brain death with MAP 55
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not be effective in
preventing catecholamine
release or maintaining BP
control

-there is significant HD
response to surgical
stimuli in BD patients
-isoflurane suppressed BP
response to noxious
stimuli, but this also
resulted in hypotension
-MAC-BAR for brain
only isoflurane group
substantially exceeded
MAC-BAR for the
whole-body group
-brain only anesthesia
group exhibited
spontaneous movement
with noxious stimuli
-whole-body
administration of
isoflurane inhibits CV
responses to noxious
stimuli, but causes a
substantial decrease in
MAP
-successful titration of
preload, afterload, HR,
and contractility achieves
optimal cardiac
performance
-concrete parameters and
recommendations for HD
normal values and
treatment
-specific drug
recommendations

-norepinephrine and
epinephrine should be
tapered off rapidly in
favor of dopamine and
dobutamine
-dysfunction of the
potential donor liver can
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 5.3 after 1 hour and 52  9.9 after 6 hours
- Cited Koo et al. (1999) who found similar
activation of adhesion molecules in human
cadaveric kidneys before reperfusion

(2000)

Pratschke et al.
(1999)

Peer-reviewed,
published
overview

-early HTN phase and late normotensive or
hypotensive phase (loss of autonomic tone)

Tuttle-Newhall
et al. (2003)

Monograph

Pennefather,
Dark, and

Prospective
observational

-causes of HDI: hypovolemia (trauma or
DI), decreased vascular tone, myocardial
depression
-clinical experience has demonstrated that
normalization of HD parameters with
volume replacement, inotropes, and careful
administration of vasoconstrictors is
associated with good transplant outcomes
(immediate allograft function)
-BD terminates PNS activity resulting in
unopposed SNS stimulation (autonomic
storm)
-loss of baroreceptor function causes
uncoupling of ANS and CV function
causing the subsequent normotensive or
hypotensive state
-unopposed vasodilation and impaired
myocardial function (injury during
autonomic storm and severe catecholamine
depletion)
-α agonist may be appropriate due to low
SVR resulting from sympathectomy, but
should be avoided whenever possible
-dopamine can cause potentially harmful
decrease in hepatic mitochondrial redox
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be reduced to some extent
by maintaining
normotension
-both progressive liver
dysfunction & infiltration
of neutrophils can cause
increased
immunogenicity of the
potential donor organ,
decreased organ viability,
& increased primary graft
dysfunction, acute
rejection, and lower graft
survival rates
-both initial and late
circulatory changes can
cause severe ischemic
damage and worsen
transplant outcomes
-both the ischemia and
the reperfusion cause
tissue injury
-brain dead organs have
higher immunogenicity
than living donors (if both
are normotensive)
-ischemic insults
happening near the time
of organ transplantation
are risk factors for late
failure for the transplant
-HDI in the donor can
cause organ dysfunction
after transplantation
-increased vascular
resistance that exceed
perfusion pressure causes
end organ ischemia in rats
(Herijgers et al., 1996)
-recommends pressor
therapy guided by PAC or
TEE

-procurement causes
significant HD changes
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Bullock (1993)

study in 14 brain
dead patients (10
thoracic/
abdominal
donors and 4
abdominal only
donors)

Rhee et al.
(2012)

Observational
study- animals
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state and renal function in recipient can be
impaired by high-dose dopamine in donor
-serial plasma catecholamine concentrations
measured in donors who did not receive
dopamine (could not measure due to
interference when dopamine was used- 9
patients)
-consistent biphasic response in 1st 30
minutes: early increase in SVR and PAWP
-by 30 minutes, SVR, PVR, MAP, PAWP,
and CVP decrease, and HR and CI increase
-two patients suffered a precipitous drop in
SVR and PAWP likely due to dilation
which caused significant decrease in CI and
MAP- IVF bolus restored CI and MAP in
both patients
-intermittent surgical manipulation affected
accuracy of HD measurements
-increased SVR and PAWP at 30 minutes
and before thoracotomy suggests increased
myocardial contractility perhaps due to
endogenous catecholamines
-vasoconstriction theories: spinal
vasoconstrictor reflex, reflex spinal
stimulation of adrenal medulla, residual
brain stem function (U.K. study- not whole
brain death declaration model)
-vasodilation theory: late decrease in SVR
due to vasodilation from epinephrine
secretion
-renovascular autoregulation can be
monitored using the renovascular reactivity
index (RVx)
-autoregulation is mediated by vascular
reactivity, which is defined by Lee et al.
(2009) as low-frequency diameter changes
in resistance vessels in response to changes
in ABP
RBF decrease Perfusion
from baseline pressure
75%
60
50%
45
25%
40
CBF decrease
from baseline
75%
50%
25%

Perfusion
pressure
30
25
15

that may alter organ
perfusion
-organ perfusion may be
impaired by inotropes
-suggests using PAC to
minimize use of inotropes

-renovascular
autoregulation, as
measured by RVx, is
impaired before cerebral
autoregulation during
shock in piglets
-BP does not necessarily
indicate renovascular
compromise
-renovascular
autoregulation is lost
before changes in BP
occur
-although clinically BP is
used as indicator for renal
perfusion, results here
show that BP does not
accurately reflect RBF
-renovascular
autoregulation is similar
to cerebrovascular
autoregulation
-kidney is more
dependent on CO whereas
brain is perfusiondependent
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Ono et al.
(2013)

Prospective
observational
study

-cerebral autoregulation during CPB
monitored by generating a cerebral
oximetry index
-lower limit of cerebral autoregulation
determined for 348 patients
-AKI developed within 7 days in 121
patients

Westphal et al.
(2012)

Guidelines
constructed by
experts after
extensive
literature review

Bijker et al.
(2007)

Observational,
retrospective
cohort study of
non-cardiac
surgery patients
in the
Netherlands

-MAP > 65 mmHg or systolic > 90 mmHg
-excessive use of pressors can cause
arrhythmias, worsen hypotension
(dobutamine), or cause intense
vasoconstriction causing ischemia to organs
-β agonist therapy may be helpful in low
CO states causing hypoperfusion
-vasopressin care be used as a pressor and
DI treatment; may help stabilize BP and
wean off catecholamine infusions
-incidence of intraoperative hypotension
according to different threshold values was
calculated, and the effect of a defined
minimal duration of a hypotensive episode
was studied
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-shock state results from
this study may be
different than shock from
vasoplegia and other
causes
-average MAP during
CPB did not differ
-patients who developed
AKI had higher MAP at
the limit of autoregulation
and duration and degree
to which MAP was below
the autoregulation
threshold (mmHg x
min/hr of CPB)
-MAPs below the lower
limit of autoregulation
were associated with
development of AKI
-drug choice should be
based on physiological
principles because there
are no randomized studies
for best choice of pressor
-no consensus regarding
maximum catecholamine
use

-no widely accepted
definition exists of
intraoperative
hypotension, therefore
there is generalizability of
studies associating poor
outcomes with
intraoperative
hypotension
*Abbreviations in table defined: CO (cardiac output), DI (diabetes insipidus), AKI (acute kidney injury), CPB
(cardiopulmonary bypass), ABP (arterial blood pressure), RBF (renal blood flow), CBF (cerebral blood flow), SVR
(systemic vascular resistance), PVR (pulmonary vascular resistance), PAWP (pulmonary artery wedge pressure),
CVP (central venous pressure), HD (hemodynamic), HDI (hemodynamic instability), HR (heart rate), CI (cardiac
index), IVF (intravenous fluid), BD (brain death), PAC (pulmonary artery catheter), MAP (mean arterial pressure),
kg (kilogram), BP (blood pressure), AS (autonomic storm), SNS (sympathetic nervous system), PNS (peripheral
nervous system), ANS (autonomic nervous system), CV (cardiovascular), TEE (transesophageal echocardiogram),
HTN (hypertension), HRT (hormone replacement therapy), EF (ejection fraction), bpm (beats per minute), BUN
(blood urea nitrogen), mcg (micrograms), min (minute), SBP (systolic blood pressure), UO (urine output), PaO 2
(partial pressure of oxygen in arterial blood), Hgb (hemoglobin), HES ( hydroxyethyl starch), FiO2 (fraction of
inspired oxygen)
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Figure 1. Frequencies displayed of the mean MAP for each case.
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Figure 2. Frequencies displayed of the mean end-tidal concentration of volatile anesthetic gas for
cases in which volatile anesthetic gas was used.
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Appendix A
2010 American Academy of Neurology Guidelines for Diagnosis of Brain Death
Checklist for determination of brain death
Prerequisites (all must be checked)
▫ Coma, irreversible and cause known
▫ Neuroimaging explains coma
▫ CNS depressant drug effect absent (if indicated toxicology screen; if barbiturates given, serum
level 10 g/mL)
▫ No evidence of residual paralytics (electrical stimulation if paralytics used).
▫ Absence of severe acid-base, electrolyte, endocrine abnormality
▫ Normothermia or mild hypothermia (core temperature 36°C)
▫ Systolic blood pressure 100 mmHg
▫ No spontaneous respirations
Examination (all must be checked)
▫ Pupils nonreactive to bright light
▫ Corneal reflex absent
▫ Oculocephalic reflex absent (tested only if C-spine integrity ensured)
▫ Oculovestibular reflex absent
▫ No facial movement to noxious stimuli at supraorbital nerve, temporomandibular joint
▫ Gag reflex absent
▫ Cough reflex absent to tracheal suctioning
▫ Absence of motor response to noxious stimuli in all 4 limbs (spinally mediated reflexes are
permissible)
Apnea testing (all must be checked)
▫ Patient is hemodynamically stable
▫ Ventilator adjusted to provide normocarbia (PaCo2 34 – 45 mmHg)
▫ Patient preoxygenated with 100% FiO2 for 10 minutes to PaO2 200 mmHg
▫ Patient well-oxygenated with a PEEP of 5 cm of water
▫ Provide oxygen via a suction catheter to the level of the carina at 6 L/min or attach T-piece
with CPAP at 10 cm H2O
▫ Disconnect ventilator
▫ Spontaneous respirations absent
▫ Arterial blood gas drawn at 8 –10 minutes, patient reconnected to ventilator
▫ PCO2 60 mmHg, or 20 mmHg rise from normal baseline value
OR:
▫ Apnea test aborted
Ancillary testing (only 1 needs to be performed; to be ordered only if clinical examination cannot
be fully performed due to patient factors, or if apnea testing inconclusive or aborted)
▫ Cerebral angiogram
▫ HMPAO SPECT
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▫ EEG
▫ TCD
Time of death (DD/MM/YY) _______________________
Name of physician and signature ____________________
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Appendix B
Neuman’s Systems Model

Neuman’s System Model copyright 1970 by Dr. Betty Neuman. Reproduced with permission.
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Appendix C
Neuman’s System Model Applied to Brain Dead Donor

Stressors

OR Physiologic Stressors:
-incision
-surgical manipulation
-sternotomy

Patient

Cause of ↑ ICP

Internal cause (i.e. stroke)

↑ ICP

External cause (i.e.
head trauma)

Blood pressure
variation

Individual

Autonomic storm

Environments

Brain death

Interacting
Variables

